IMVT

$28.395.05%-1.51

After Hours: 28.01-0.38 -1.34%

Immunovant Inc (IMVT)

Immunovant Inc Stock (IMVT) Forecast

The Immunovant Inc (IMVT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $28.46, representing a +0.25% increase from the current price of $28.39. The highest analyst price target is $29.02, and the lowest is $27.90.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month IMVT Price Target

Average 32.97 (+16.13% Upside)

Is Immunovant Inc (IMVT) A Buy Now?

Oscillators

Name	Value	Action
RSI(14)	39.32	Neutral
STOCH(9,6)	59.12	Neutral
STOCHRSI(14)	70.65	Neutral
MACD(12,26)	-1.14	Buy
ADX(14)	32.59	Sell
William %R	-48.55	Neutral
CCI(14)	3.12	Neutral

Buy: 1 · Sell: 1 · Neutral: 5Summary: Neutral

Moving Averages

Period	Simple	Exponential
MA10	28.94 Sell	28.99 Sell
MA20	28.70 Sell	29.59 Sell
MA50	33.37 Sell	32.30 Sell
MA100	36.63 Sell	33.53 Sell
MA200	32.10 Sell	31.51 Sell

Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell

According to our latest analysis, IMVT could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 11 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on IMVT, as trading bearish markets can be challenging and may result in losses.

RSI (Relative Strength Index): The RSI(14) value of 39.32 indicates that IMVT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
STOCH (Stochastic Oscillator): The STOCH value of 59.12 indicates that IMVT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 70.65 indicates that IMVT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
ADX (Average Directional Index): The ADX value of 32.59 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
CCI (Commodity Channel Index): A CCI(14) value of 3.12 indicates that IMVT is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term IMVT price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Immunovant Inc financial reports and earnings history, Immunovant Inc (IMVT) stock could reach $80.37 by 2030, $165.50 by 2040 and $178.84 by 2050. See the projected annual prices until 2050 of the Immunovant Inc stock below:

Immunovant Inc (IMVT) is expected to reach an average price of $125.11 in 2035, with a high prediction of $127.34 and a low estimate of $112.01. This indicates an +340.67% change from the last recorded price of $28.39.
Immunovant Inc (IMVT) stock is projected to chart a bullish course in 2040, with an average price target of $157.67, representing an +455.38% change from its current level. The forecast ranges from a conservative $123.37 to a sky-high $165.50.
Our analysts predict Immunovant Inc (IMVT) to change +555.62% by 2045, soaring from $130.68 to an average price of $186.13, potentially reaching $193.47. While $130.68 is the low estimate, the potential upside is significant.
Immunovant Inc (IMVT) stock is expected to climb by 2050, reaching an average of $177.86, a +526.50% change from its current level. However, a wide range of estimates exists, with high and low targets of $178.84 and $125.49, respectively, highlighting the market's uncertainty.

Immunovant Inc Stock (IMVT) Year by Year Forecast

Immunovant Inc Stock (IMVT) Price Forecast for 2026

The predicted value for Immunovant Inc (IMVT) in 2026 is set at an average of $31.40. Estimates vary from a peak of $45.42 to a trough of $22.79, indicating an +10.61% surge from the present price of $28.39.

Month	Average	Low	High	Change from today's price
December, 2026	$28.89	$27.90	$29.02	+1.77%

Immunovant Inc Stock (IMVT) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Immunovant Inc (IMVT) is $31.35, with a high forecast of $41.47 and a low forecast of $27.54. This indicates an +10.44% increase from the last price of $28.39.

Month	Average	Low	High	Change from today's price
January, 2027	$28.13	$28.12	$30.11	-0.93%
February, 2027	$27.64	$27.57	$29.08	-2.64%
March, 2027	$28.10	$27.54	$28.68	-1.02%
April, 2027	$29.18	$28.10	$29.71	+2.77%
May, 2027	$28.74	$28.61	$29.50	+1.22%
June, 2027	$29.23	$28.23	$29.31	+2.96%
July, 2027	$29.78	$28.60	$29.92	+4.91%
August, 2027	$30.86	$29.63	$31.24	+8.72%
September, 2027	$33.23	$30.60	$33.37	+17.04%
October, 2027	$32.64	$32.42	$33.76	+14.98%
November, 2027	$37.61	$32.37	$38.40	+32.49%
December, 2027	$41.10	$37.46	$41.47	+44.76%

Immunovant Inc Stock (IMVT) Price Forecast for 2028

In 2028, Immunovant Inc (IMVT) is projected to reach an average price of $52.18, with a high projection of $60.96 and a low estimate of $40.74. This indicates an +83.78% rise from the last price of $28.39.

Month	Average	Low	High	Change from today's price
January, 2028	$44.51	$40.74	$44.54	+56.77%
February, 2028	$48.20	$44.12	$48.35	+69.79%
March, 2028	$48.80	$45.08	$51.00	+71.88%
April, 2028	$50.04	$46.70	$50.87	+76.26%
May, 2028	$47.98	$47.34	$50.32	+69.01%
June, 2028	$47.38	$47.04	$49.59	+66.87%
July, 2028	$55.10	$47.85	$55.56	+94.07%
August, 2028	$55.81	$54.62	$58.22	+96.58%
September, 2028	$53.68	$53.30	$56.74	+89.09%
October, 2028	$57.81	$53.70	$60.57	+103.64%
November, 2028	$59.25	$55.05	$59.48	+108.70%
December, 2028	$57.55	$57.19	$60.96	+102.72%

Immunovant Inc Stock (IMVT) Price Forecast for 2029

The 2029 price forecast for Immunovant Inc Stock (IMVT) is $74.51 on average, with a high prediction of $85.55 and a low estimate of $56.82. This represents an +162.44% increase from the previous price of $28.39.

Month	Average	Low	High	Change from today's price
January, 2029	$71.36	$56.82	$81.51	+151.37%
February, 2029	$72.39	$69.59	$74.48	+154.97%
March, 2029	$78.38	$70.72	$80.13	+176.09%
April, 2029	$82.33	$75.36	$85.55	+190.00%
May, 2029	$75.53	$75.49	$82.57	+166.03%
June, 2029	$76.59	$74.86	$80.77	+169.78%
July, 2029	$74.31	$71.40	$78.53	+161.75%
August, 2029	$69.79	$69.59	$74.56	+145.84%
September, 2029	$73.95	$69.61	$75.25	+160.48%
October, 2029	$71.35	$68.45	$75.37	+151.32%
November, 2029	$72.62	$69.78	$76.50	+155.81%
December, 2029	$75.48	$71.06	$76.82	+165.88%

Immunovant Inc Stock (IMVT) Price Forecast for 2030

Immunovant Inc Stock (IMVT) is expected to reach an average price of $72.23 in 2030, with a high forecast of $80.37 and a low forecast of $64.08. This signifies an +154.44% surge from the last price of $28.39.

Month	Average	Low	High	Change from today's price
January, 2030	$75.73	$74.44	$80.37	+166.74%
February, 2030	$77.19	$74.14	$77.34	+171.90%
March, 2030	$76.57	$75.24	$78.33	+169.70%
April, 2030	$76.29	$72.54	$79.72	+168.71%
May, 2030	$73.20	$72.62	$77.89	+157.84%
June, 2030	$73.20	$71.75	$74.81	+157.82%
July, 2030	$71.39	$69.03	$73.91	+151.45%
August, 2030	$70.38	$67.75	$71.63	+147.90%
September, 2030	$66.67	$64.08	$71.16	+134.84%
October, 2030	$66.16	$65.50	$68.43	+133.06%
November, 2030	$69.54	$65.82	$69.87	+144.94%
December, 2030	$70.50	$68.19	$70.65	+148.32%

Similar to IMVT